Anticorps Monoclonal anti-NeutraKine® IL-17A
NeutraKine® IL-17A Monoclonal Antibody for Single Cell (Intra)
Hôte / Isotype
Mouse / IgG1
Réactivité testée
Humain
Applications
Single Cell (Intra)
Conjugaison
5CFLX Fluorescent Dye
CloneNo.
1F3E3
N° de cat : G69021-1-5C
Synonymes
Galerie de données de validation
Applications testées
| Résultats positifs en Single Cell (Intra) | 10x Genomics Gene Expression Flex with Feature Barcodes and Multiplexing product. | 
Dilution recommandée
| Application | Dilution | 
|---|---|
| SINGLE CELL (INTRA) | SINGLE CELL (INTRA) : <0.5ug/test | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, check data in validation data gallery | |
Informations sur le produit
G69021-1-5C cible NeutraKine® IL-17A dans les applications de Single Cell (Intra) et montre une réactivité avec des échantillons Humain
| Réactivité | Humain | 
| Hôte / Isotype | Mouse / IgG1 | 
| Clonalité | Monoclonal | 
| Type | Anticorps | 
| Immunogène | NeutraKine® IL-17A Protéine recombinante HZ-1113 | 
| Nom complet | interleukin 17A | 
| Symbole du gène | IL-17A | 
| Identification du gène (NCBI) | 3605 | 
| Conjugaison | 5CFLX Fluorescent Dye | 
| Forme | Liquide | 
| Méthode de purification | |
| Tampon de stockage | PBS with 1mM EDTA and 0.09% sodium azide | 
| Conditions de stockage | 2-8°C Stable for one year after shipment. 20ul contiennent 0,1% de BSA. | 
Informations générales
IL17A, also named as IL-17, is a proinflammatory cytokine. IL-17, synthesized only by memory T cells and natural killer cells, has pleiotropic effects, mainly in the recruitment and activation of neutrophils. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. The IL-17 receptor is a type I transmembrane protein, that is widely expressed on epithelial cells, fibroblasts, B and T cells, and monocytic cells. In psoriatic skin lesions, both Th17 cells and their downstream effector molecules, e.g. IL-17 and IL-22, are highly increased. 
This antibody can be used to neutralize the bioactivity of IL-17A.


